Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis

William Tillett; Gavin Shaddick; Amelia Jobling; Ayman Askari; Annie Cooper; Paul Creamer; Gavin Clunie; Philip S. Helliwell; Jana James; Lesley Kay; Eleanor Korendowych; Suzanne Lane; Jonathon Packham; Ragai Shaban; Matthew L. Thomas; Lyn Williamson; Neil McHugh

doi:10.1093/rheumatology/kew433

Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis

William Tillett, Gavin Shaddick, Amelia Jobling, Ayman Askari, Annie Cooper, Paul Creamer, Gavin Clunie, Philip S. Helliwell, Jana James, Lesley Kay, Eleanor Korendowych, Suzanne Lane, Jonathon Packham, Ragai Shaban, Matthew L. Thomas, Lyn Williamson, Neil McHugh

Department of Mathematics

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	kew433
Pages (from-to)	603-612
Number of pages	10
Journal	Rheumatology (United Kingdom)
Volume	56
Issue number	4
DOIs	https://doi.org/10.1093/rheumatology/kew433
Publication status	Published - 1 Apr 2017

Keywords

Anti-TNF
csDMARDs
Outcomes research
Psoriatic arthritis
Work disability

Access to Document

10.1093/rheumatology/kew433

Cite this

Tillett, W., Shaddick, G., Jobling, A., Askari, A., Cooper, A., Creamer, P., Clunie, G., Helliwell, P. S., James, J., Kay, L., Korendowych, E., Lane, S., Packham, J., Shaban, R., Thomas, M. L., Williamson, L., & McHugh, N. (2017). Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis. Rheumatology (United Kingdom), 56(4), 603-612. Article kew433. https://doi.org/10.1093/rheumatology/kew433

@article{aec2aa975c13452398e08c6bd90519cb,

title = "Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis",

keywords = "Anti-TNF, csDMARDs, Outcomes research, Psoriatic arthritis, Work disability",

author = "William Tillett and Gavin Shaddick and Amelia Jobling and Ayman Askari and Annie Cooper and Paul Creamer and Gavin Clunie and Helliwell, {Philip S.} and Jana James and Lesley Kay and Eleanor Korendowych and Suzanne Lane and Jonathon Packham and Ragai Shaban and Thomas, {Matthew L.} and Lyn Williamson and Neil McHugh",

year = "2017",

month = apr,

day = "1",

doi = "10.1093/rheumatology/kew433",

language = "English",

volume = "56",

pages = "603--612",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "4",

}

Tillett, W, Shaddick, G, Jobling, A, Askari, A, Cooper, A, Creamer, P, Clunie, G, Helliwell, PS, James, J, Kay, L, Korendowych, E, Lane, S, Packham, J, Shaban, R, Thomas, ML, Williamson, L & McHugh, N 2017, 'Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis', Rheumatology (United Kingdom), vol. 56, no. 4, kew433, pp. 603-612. https://doi.org/10.1093/rheumatology/kew433

Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis. / Tillett, William; Shaddick, Gavin; Jobling, Amelia et al.
In: Rheumatology (United Kingdom), Vol. 56, No. 4, kew433, 01.04.2017, p. 603-612.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis

AU - Tillett, William

AU - Shaddick, Gavin

AU - Jobling, Amelia

AU - Askari, Ayman

AU - Cooper, Annie

AU - Creamer, Paul

AU - Clunie, Gavin

AU - Helliwell, Philip S.

AU - James, Jana

AU - Kay, Lesley

AU - Korendowych, Eleanor

AU - Lane, Suzanne

AU - Packham, Jonathon

AU - Shaban, Ragai

AU - Thomas, Matthew L.

AU - Williamson, Lyn

AU - McHugh, Neil

PY - 2017/4/1

Y1 - 2017/4/1

KW - Anti-TNF

KW - csDMARDs

KW - Outcomes research

KW - Psoriatic arthritis

KW - Work disability

UR - http://www.scopus.com/inward/record.url?scp=85017234328&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kew433

DO - 10.1093/rheumatology/kew433

M3 - Article

C2 - 28013211

AN - SCOPUS:85017234328

SN - 1462-0324

VL - 56

SP - 603

EP - 612

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 4

M1 - kew433

ER -

Tillett W, Shaddick G, Jobling A, Askari A, Cooper A, Creamer P et al. Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis. Rheumatology (United Kingdom). 2017 Apr 1;56(4):603-612. kew433. doi: 10.1093/rheumatology/kew433

Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritis

Keywords

Access to Document

Other files and links

Cite this